Lyell (LYEL) VP Veronica Bulis Sanchez Sells 621 Shares

What Happened

• Veronica Bulis Sanchez, Vice President & Corporate Controller at Lyell Immunopharma (LYEL), reported the sale of 621 shares on August 10, 2026. The reported weighted-average sale price was $14.34 per share (range $14.20–$14.34), for total proceeds of $8,905. This was a sale (not a purchase) executed automatically to satisfy tax withholding obligations related to the settlement of vested restricted stock units (RSUs).

Key Details

• Transaction date: 2026-08-10
• Transaction type/code: Sale (S); marked as tax-withholding disposition for vested RSUs (footnote F1/F2)
• Price: Weighted average $14.34; sale prices ranged $14.20–$14.34
• Proceeds: $8,905
• Shares owned after transaction: Not specified in the provided filing
• Filing timeliness: Filed 2026-08-11 (one day after the transaction) — appears timely under Form 4 rules
• Footnotes of note: F1 indicates shares were automatically sold to cover tax withholding on vested RSUs; F2 notes the reported price is a weighted average and a per-price breakdown is available on request

Context

• This was an automatic, routine sale to cover tax withholding from vested RSUs — a common administrative transaction that typically does not reflect an insider’s discretionary view of the company. Purchases by insiders often carry more weight for interpreting sentiment; withholding sales are primarily administrative.